Stephen D. Griffin

President and CEO at Anika Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
9 months
Director since
2026

9 months of board service in total across 1 board, counting each seat separately. Longest: Anika Therapeutics Inc., 9 months.

Anika Therapeutics Inc. Director · President and CEO
9 months · Since 2026

Chief executive roles

Anika Therapeutics Inc. · President and CEO
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 3, 2026 Anika Therapeutics Inc. Option exercise +12,840 — —
Jun 3, 2026 Anika Therapeutics Inc. Shares withheld for tax −3,769 $14.41 $54,311
Apr 30, 2026 Anika Therapeutics Inc. Open-market purchase +12,200 $12.29 $149,938
Mar 14, 2026 Anika Therapeutics Inc. Option exercise +12,824 — —
Mar 14, 2026 Anika Therapeutics Inc. Grant or award +6,412 — —
Mar 14, 2026 Anika Therapeutics Inc. Shares withheld for tax −5,944 $14.20 $84,405

Questions about Stephen D. Griffin

What boards is Stephen D. Griffin on?

Stephen D. Griffin sits on the board of Anika Therapeutics Inc.

What company is Stephen D. Griffin the CEO of?

Stephen D. Griffin is President and CEO of Anika Therapeutics Inc.

How long has Stephen D. Griffin served on boards?

Our records show at least 9 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.